China SXT Pharmaceuticals, Inc.
SXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723980
No open-market purchases or sales by China SXT Pharmaceuticals, Inc. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $6 in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding China SXT Pharmaceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 4 | 10 | +6 |
| Shares | 76.8K | 310.8K | +234.1K (+304.9%) |
| Value | $132.6K | $490.6K | +$358.0K (+270.1%) |
New holders (7)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Invesco Ltd. | 89,660 | $140.8K | 0.00% |
| Geode Capital Management, LLC | 53,671 | $85.3K | 0.00% |
| Citadel Advisors LLC | 48,759 | $77.5K | 0.00% |
| Renaissance Technologies LLC | 44,500 | $69.9K | 0.00% |
| HRT Financial LP | 26,749 | $42.0K | 0.00% |
| Two Sigma Securities, LLC | 15,449 | $24.3K | 0.00% |
| State of Wyoming | 89 | $142 | 0.00% |
Sold out (1)
Institutions that held China SXT Pharmaceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Acadian Asset Management LLC | 48 | $0 |